Income Tax Expense (Benefit) of CRESCENT BIOPHARMA, INC. from 30 Sep 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2013 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), Quarterly (USD)

CRESCENT BIOPHARMA, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,000,000 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY

CRESCENT BIOPHARMA, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $0 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q4 2024 $0 20 Sep 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $0 20 Sep 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q1 2015 $0 $0 01 Jan 2015 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q3 2014 $76,758 -$76,758 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $76,758 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $0 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.